Prophylactic indomethacin: Systematic review and meta-analysis

Archives of Disease in Childhood

Volumn 74, Issue 2 SUPPL., 1996, Pages

  Fowlie, Peter W ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Intraventricular haemorrhage; Overview; Patent ductus arteriosus; Pooled estimate; Very low birthweight

Indexed keywords

INDOMETACIN; PLACEBO;

ARTICLE; BRAIN VENTRICLE HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; NEWBORN; NEWBORN MORBIDITY; NEWBORN MORTALITY; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; VERY LOW BIRTH WEIGHT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CEREBRAL HEMORRHAGE; DUCTUS ARTERIOSUS, PATENT; HUMANS; INDOMETHACIN; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0030009188     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/fn.74.2.f81     Document Type: Article

References (35)

1. Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 1979; 95: 865.
2. Kitterman JA, Edmunds LH Jr., Gregory GA, Heymann MA, Tooley WH, Rudolph AM. Patent ductus arteriosus in premature infants: incidence and relation to pulmonary disease and management. N Eng J Med 1972; 287: 473.
3. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530-3.
4. Lipman B, Server GA, Brazy JE. Abnormal cerebral haemodynamics in preterm infants with patent ductus arteriosus. Pediatrics 1982; 69: 778-81.
5. Ment LA, Stewart WB, Duncan CC, Scott DT, Lambrecht R. Beagle puppy model of intraventricular haemorrhage: effect of indomethacin on cerebral blood flow. J Neurosurgery 1983; 58: 857-62.
6. Ment LA, Stewart WB, Ardito TA, Huang E, Madri JA. Indomethacin promotes germinal matrix maturation in the newborn beagle puppy. Stroke 1992; 23: 1132-7.
7. Edwards AD, Wyatt JS, Richardson C, Potter A, Cope M, Delpy DT, et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990; 335: 1491-5.
8. Coombs RC, Morgan MEI, Durbin GM, Booth IW, McNeish AS. Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and patenteral indomethacin. Arch Dis Child 1990; 65: 1067-71.
9. Cifuentes RF, Olley PM, Balfe JW, Radde IC, Soldin SJ. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 1979; 95: 583-7.
10. Friedman Z, Whitman V, Maisels MJ, Berman WJr, Marks KH, Vessell ES. Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants. J Clin Pharmacol 1978; 18: 272-9.
11. Herson VC, Krause PJ, Eisenfeld LI, Pontius L, Maderazo EG. Indomethacin associated sepsis in the very low birth weight infant. Am J Dis Child 1988; 142: 555-8.
12. Mulrow CD. The medical review article: state of the science. Ann Intern Med 1987; 106: 485-8.
13. Moher D, Jadad AR, Nichol G, Penam M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Controlled Clinical Trials 1995; 16: 62-73.
14. Schultz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias; dimensions of methodologic quality associated with estimates of treatment effect in controlled clinical trials. JAMA 1995; 273: 408-12.
15. Bada HS, Green RS, Pourcyrous M, Leffler CW, Korones SB, Arheart K. Indomethacin reduces relative risks of severe intraventricular haemorrhage. Ped Res 1989; 25: 353A.
16. Bandstra ES, Bauer CR, Duenas ML, Chao H, Montalvo BM, Bancalari E. Prophylactic indomethacin for prevention of intraventricular haemorrhage: neurodevelopmental follow-up. Ann Neurol 1987; 22: 427A.
17. Pourcyrous M, Bada HS, Green RS, Korones SB. Safety of indomethacin use for newborn infants. Ped Res 1988; 23: 422A.
18. Setzer ES, Morse BM, Goldberg RN, Smith M, Bancalari E. Prophylactic indomethacin and intraventricular haemorrhage in the premature. Ped Res 1984; 18: 345A.
19. Setzer ES, Torres-Arraut E, Gomez-del-Rio M, Young ML, Pacheco I, Ferrer PL, et al. Cardiopulmonary effects of prophylactic indomethacin in the very low birth weight infant. Ped Res 1984; 18: 346A.
20. Rothman KJ. In: Modem epidemiology. Boston: Little Brown, 1986.
21. Bracken MB. Statistical methods for analysis of effects of treatment in overviews of randomised trials. In: Sinclair JC, Bracken MB, eds. Effective care of the newborn infant. New York: Oxford University Press, 1992: 13-20.
22. Setzer ES, Smith M, Goulding PJ, Bandstra TE. Severity of platelet dysfunction induced by prophylactic indomethacin in the premature. Ped Res 1984; 18: 346A.
23. Mahoney L, Caldwell RL, Girod DA, Hurwitz RA, Jansen RD, Lemons JA, et al. Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 1985; 106: 801-5.
24. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Pitt BR, Taylor KJ, et al. Randomized indomethacin trial for prevention of intraventricular haemorrhage in very low birth weight infants. J Pediatr 1985; 107: 937-43.
25. Puckett CG, Cox MA, Haskins KS, Fisher DJ. Prophylactic indomethacin (I) for the prevention of patent ductus arteriosus (PDA). Ped Res 1985; 19: 358A.
26. Vincer V, Allen A, Evans J, Nwaesei C, Stinson D, Rees E, et al. Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatr Scand 1985; 76: 894-7.
27. Rennie JM, Doyle J, Cooke RWI. Early administration of indomethacin to preterm infants. Arch Dis Child 1986; 61: 233-8.
28. Bandstra ES, Duenas ML, Rodriguez I, Chao H, Montalvo BM, Bauer CR, et al. Prophylactic indomethacin for the prevention of intraventricular haemorrhage (IVH): neurodevelopmental follow-up. Ped Res 1987; 21: 391A.
29. Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr 1987, 111: 749-54.
30. Hanigan WC, Kennedy G, Roemisch F, Anderson R, Cusack T, Powers W. Administration of indomethacin for the prevention of periventricular haemorrhage in high-risk neonates. J Pediatr 1988; 112: 941-7.
31. Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJW, Scott DT, et al. Randomized low-dose indomethacin trial for prevention of intraventricular haemorrhage in very low birth weight neonates. J Pediatr 1988; 112: 948-55.
32. Bandstra ES, Montalvo BM, Goldberg RN, Pacheco I, Ferrer PL, Flynn J, et al. Prophylactic indomethacin for prevention of intraventricular haemorrhage in premature infants. Pediatrics 1988; 82: 533-42.
33. Bada HS, Green RS, Pourcyrous M, Leffler CW, Korones SB, Magill HL, et al. Indomethacin reduces the risks of severe intraventricular haemorrhage. J Pediatr 1989; 115: 631-7.
34. Ment LR, Oh W, Ehrenkranz RA, Phillip AGS, Vohr B, Allan W, et al. Low-dose indomethacin therapy and extension of intraventricular haemorrhage: a multicentre randomized trial. J Pediatr 1994; 124: 951-5.
35. Ment LR, Oh W, Ehrenkranz RA, Phillip AGS, Vohr B, Allan W, et al. Low-dose indomethacin and prevention of intraventricular haemorrhage: a multicentre randomized trial. Pediatrics 1994; 93: 543-50.